Hot Investor Mandate 1: China-Based Firm Invests in Therapeutics, Medical Devices, and Diagnostics in the USA

15 Dec

A subsidiary investment firm of a leading China-focused private equity fund is actively looking for equity investment, in-licensing, or add-on acquisition opportunities to augment its healthcare portfolio. The size of investment varies depending on the deal. The firm considers businesses in China and the United States.

Within healthcare, the firm considers a wide range to technologies including pharmaceuticals, medical devices, diagnostic tools, and healthcare IT. The firm is interested in products with large market potential in China in a wide range of therapeutic categories. The firm is open to companies at various stages of development but prefers products that have obtained human proof-of-concept.

The firm looks for products with a China angle and may request China distribution rights on a case-by-case basis.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: